Navigation Links
Kalorama Report: Sizable Number of Acquisitions and Joint Ventures in Molecular Diagnostics
Date:8/12/2014

NEW YORK, Aug. 12, 2014 /PRNewswire/ -- Molecular diagnostic companies are partnering to survive, according to a recent Kalorama Information report.  The healthcare market research publisher said that the 5.5 billion dollar molecular diagnostics market grew by combination last year, where possible partnerships were formed and in some cases outright purchases.  The report said numerous acquisitions and joint ventures occurred in 2013 and will change the market today.   

The finding was made in Kalorama's The World Market for Molecular Diagnostics Update, the firm's latest look at the molecular IVD segment that can be found at: http://www.marketresearch.com/redirect.asp?progid=86503&url=http%3A%2F%2Fwww%2Ekaloramainformation%2Ecom%2FMolecular%2DDiagnostics%2DMonth%2D7969379%2F.

"A dynamic market encourages players to bolster their offerings with acquisitions, collaborations and licensing agreements," said Shara Rosen, Kalorama analyst and author of the report.

The report said the complexity of molecular testing encourages companies to augment their capabilities via collaborations and licensing agreements. Examples include:

  • Exosome Diagnostics U.S. with Eli Lilly, cancer PGx
  • Illumina U.S. with Global Genomics cardiac markers
  • Life Technologies/Thermo Fisher U.S. with Merck Serono drug PG

Collaboration is not always possible with companies remaining independent entities and thus many companies made purchase to cover gaps in expertise.  Kalorama cited the following as examples of 17 significant 2013 purchases where IVD companies acquired molecular dx startups or small concerns.

  • bioMerieux's purchase of BioFire Diagnostics
  • Grifol's purchase of Novartis's blood bank testing
  • Illumina's continued expansion into clinical markets (Next Bio, Advanced Liquid Logic)
  • Qiagen's purchase of CLC Bio.
  • Sysmex's purchase of Inostics digital PCR from Indivumed

Kalorama goes into greater detail about these combinations in its report, The World Market for Molecular Diagnostics Update.   Market analysis in the covers world markets for in vitro diagnostics, particularly North America and Western Europe. Segment markets within molecular diagnostics are broken out, and trends and partnerships are given extensive discussion.

About Kalorama Information -- Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.

Contact:
Bruce Carlson
(212) 807-2622
bcarlson@kaloramainformation.com

Logo - http://photos.prnewswire.com/prnh/20140801/132634


'/>"/>
SOURCE Kalorama Information
Copyright©2014 PR Newswire.
All rights reserved

Related biology news :

1. Report: Captive lion reintroduction programs in Africa operate under conservation myth
2. Report: Bushmeat pushes Southern African species to the brink
3. Report: Cleanup of some contaminated groundwater sites unlikely for decades
4. Report: Water and Agriculture in Canada: Towards Sustainable Management of Water Resources
5. DNA Microarray 2013 Market Report: A Focus on Sales Growth
6. Report: Climate change to shift Kenyas breadbaskets
7. UN climate report: Pricing of CO2 emissions critical
8. UGA study finds theres not always safety in numbers when it comes to extinction risk
9. Fighting bacterias strength in numbers
10. New report puts real numbers behind history of oyster reefs
11. Moderate drinking decreases number of new brain cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2019)... , ... May 21, 2019 , ... Suvoda LLC ... drug supply chain management, has been named one of Inc. Magazine’s Best Workplaces for ... full list , now featured on Inc.com and hitting the newsstands on May 28, ...
(Date:5/21/2019)... ... 20, 2019 , ... The ASGCT Clinical Trials Finder is a ... the United States. Data curated daily from ClinicalTrials.gov ensures the most up-to-date and applicable ... volunteered to assist in the development of the ASGCT Clinical Trials Finder ...
(Date:5/16/2019)... ... May 16, 2019 , ... In a FDA-contracted Standard Coordinating Body ... March 18-19 of this year, Asymmetrex founder and director James L. Sherley, ... counting therapeutic adult tissue stem cells. Many of the gathered participants dismissed this ...
Breaking Biology News(10 mins):
(Date:5/15/2019)... ... May 15, 2019 , ... Milton Hershey School® has named William ... work within the biomedical industry, where he is changing lives by creating solutions to ... “William Harding epitomizes the vision of our founders – Milton and Catherine Hershey – ...
(Date:5/8/2019)... Calif. (PRWEB) , ... May 07, 2019 , ... Standing at 16.2 hands, Atlas is ... too, participating in a drill team and barrel racing, among other activities. When loping ... ligament. He went from being a busy horse to only being able to walk. ...
(Date:5/2/2019)... (PRWEB) , ... April 30, ... ... the International Organization for Standardization ISO 9001:2015 standard, REPROCELL USA Inc. has ... customer requirements. In addition, REPROCELL USA Inc. aims to enhance customer satisfaction ...
(Date:5/2/2019)... ... 2019 , ... Boston Robotic Hair Restoration announces the most ... days of painful hair transplant procedures. Boston Robotic Hair Restoration offers the newest, ... intelligent solution to offer a minimally invasive procedure. With the ARTAS® iX robotics, ...
Breaking Biology Technology: